Healthcare
Healthcare Investment Banking Group
Finding financial solutions across every sector of the healthcare ecosystem.
A full-service healthcare investment banking practice offering a best-in-class combination of deep sector knowledge, strong industry relationships, and broad product expertise.
Stifel’s Global Healthcare Investment Banking Group is comprised of 47 professionals covering all segments of the healthcare industry. The team, located in New York, San Francisco, London, Toronto, and Montreal, has substantial experience in assisting companies with all types of financing and M&A assignments. The Global Healthcare Group is dedicated to building long-term relationships with its clients through senior level attention. Since the formation of the Global Healthcare Group in Q4 2010, the team have helped raise over $79.1 billion for over 225 healthcare companies in over 440 transactions. Over the same period, members of the Global Healthcare Group have advised on over 105 announced M&A transactions, including over 30 cross-border assignments.
Our team provides clients with strategic advisory and capital-raising services designed to support growth companies and their investors during all stages of their development. We offer equity and debt capital markets services, including book running leading IPOs, follow-ons, and convertible note issuances. The Global Healthcare Group is supported by M&A advisory with extensive cross-border expertise, access to private capital markets through SPACs and 144A solutions, as well as activism defense and restructuring.
Areas of Expertise
Biopharma
The biopharma sector is advancing at an unprecedented pace, driven by innovation and growth from small to large companies across all stages of development and therapeutic areas. Stifel’s Biopharma team is uniquely positioned to serve the needs of our clients in all types of financing and M&A assignments via our deep understanding of the biopharma landscape, and our extensive relationships and transaction experience.
Healthcare Services
The healthcare services landscape is constantly shifting, driven by changes in regulations, reimbursement, and advancements in technology. Stifel’s Healthcare Services Team works to stay abreast of these changes and is ideally positioned to serve the needs of our clients in all types of financing and M&A assignments via relationships, recent mandates, and years of thought leadership across a broad range of healthcare sub-sectors including Alternate Site, Behavioral Health, Payor Services, Pharma Services, and Physician Groups.
HealthTech
Technologies are rapidly advancing the automation of workflows across the healthcare ecosystem, the development and efficacy of treatments, and the way in which care is provided in-person and remotely. Stifel’s Healthcare Technology team brings a wealth of M&A and financing experience advising companies delivering software, digital health, data-driven, and technology-enabled solutions to providers, payors, pharmaceutical companies, and patients.
Medtech
The Medtech sector is advancing at an unprecedented pace, driven by innovation and growth from small to large companies across all Medtech subsectors. Stifel’s Medtech team is uniquely positioned to serve the needs of our clients in all types of financing and M&A assignments via our deep understanding of the Medtech landscape, and our extensive relationships and transaction experience.
Tools & Diagnostics
The life science tools & diagnostics sector is transforming at amazing speeds. Enabled by a broad array of new technologies, our ability to better understand all facets of the human genome has improved exponentially; all the while being done at greater efficiency and dramatically reduced costs. This widening knowledge set is enabling faster and more productive drug discovery, disease diagnosis and AI-enabled prognostic clinical capabilities. Stifel’s Life Science Tools & Diagnostics team is uniquely positioned to serve the needs of our clients in all types of financing and M&A assignments via our broad domain expertise, deep understanding of the competitive landscape, and our extensive relationships and transaction experience.
Read our June 2024 Oncology Market Report, a summary of recent deal activity, and new developments from the American Society of Clinical Oncology conference.
Learn MoreNotable Transactions
$ 175,000,000
Joint Bookrunner
$ 202,000,000
Joint Bookrunning Manager
$ 219,200,000
Joint Bookrunner
$ 150,000,000
Joint Bookrunner
Advisor to Buyer
$ 75,000,000
Joint Bookrunner
Advisor to Pieris
$ 50,000,000
Joint Bookrunner
$ 257,600,000
Joint Bookrunner
Advisor to Seller
$ 402,500,000
Joint Bookrunner
$ 60,000,000
Joint Bookrunner & Joint Placement Agent
Advisor to Buyer
Sole Financial Advisor
$ 575,000,000
Joint Bookrunner
$ 362,250,000
Joint Bookrunner
$ 187,680,000
Joint Bookrunner
$ 258,750,000
Joint Bookrunning Manager
$ 200,536,320
Joint Placement Agent
$ 200,000,000
Joint Bookrunner
$ 258,750,000
Joint Bookrunner
$ 130,000,000
Joint Bookrunner
Advisor to Seller
$ 100,000,000
Lead Financial Advisor
$ 33,900,000
Sole Bookrunner
$ 128,000,000
Financial Advisor
Advisor to Seller
$ 310,000,000
Advisor to Seller
Advisor to Seller
Advisor to Buyer
€ 52,500,000
Exclusive Debt Advisor
$ 174,400,000
Joint Bookrunner
$ 60,000,000
Joint Bookrunner
$ 374,325,000
Joint Bookrunner
$ 75,000,000
Sole Bookrunner
$ 94,300,000
Advisor to Sientra
$ 121,600,000
Advisor to Seller
$ 280,000,000
Joint Placement Agent
$ 201,250,000
Joint Bookrunner
$ 110,000,000
Joint Bookrunner
Advisor to Seller
C$ 23,011,788
Joint Bookrunner
Financial Advisor
$ 240,100,310
Joint Bookrunner
$ 150,000,000
Joint Bookrunner
$ 180,000,000
Joint Placement Agent
$ 482,999,902
Joint Bookrunner
$ 140,000,000
Joint Bookrunner
Advisor to Seller
£ 31,000,000
Joint Bookrunner, Joint Corporate Broker, NOMAD
$ 632,540,250
Joint Bookrunner
$ 34,400,000
Advisor to Buyer
C$ 6,000,000
$ 160,125,000
Joint Bookrunner
$ 345,144,000
Joint Bookrunner
$ 230,000,000
Joint Bookrunner
$ 20,300,000
Left Bookrunner
$ 180,000,000
Joint Placement Agent
$ 100,000,000
Advisor to Buyer
$ 300,000,000
Joint Bookrunner
Advisor to Seller
$ 245,000,000+
Advisor to Licensee
Advisor to Seller
$ 111,536,216
Joint Bookrunner
$ 150,150,000
Joint Bookrunner
$ 517,500,000
Joint Bookrunner
€ 154,430,010
Advisor to Seller
$ 100,000,000
Joint Bookrunner
$ 90,833,010
Advisor to Buyer
Advisor to Seller
$ 115,000,000
Joint Bookrunner
$ 250,070,000
Joint Bookrunner
$ 130,000,000
Joint Bookrunner
$ 345,057,500
Joint Bookrunner
£ 10,000,000
Joint Bookrunner
$ 120,000,000
Joint Bookrunner
$ 137,200,000
Joint Bookrunner
$ 200,000,000
Investment Banker for Tricida
£ 176,000,000
Financial Advisor
$ 460,000,000
Joint Bookrunner
$ 220,800,000
Joint Bookrunner
$ 20,300,000
Sole Placement Agent and Nomad
$ 100,000,000
Joint Bookrunner
$ 227,843,965
Joint Bookrunner
Advisor to Seller
$ 120,000,000
Left Bookrunner
$ 115,799,748
Joint Bookrunner & Joint Placement Agent
$ 65,010,000
Joint Bookrunner
Advisor to Seller
$ 300,375,000
Joint Bookrunner
$ 64,000,000
Advisor to Seller
$ 850,000,000
Financial and Capital Markets Advisor
$ 115,000,000
Joint Bookrunner
£ 64,000,000
Sole Bookrunner, Sole Placement Agent, Sole Broker and Nomad
$ 58,079,577
Joint Bookrunner
$ 124,800,000
Joint Bookrunner
$ 260,000,000
Advisor to Seller
$ 84,249,986
Joint Bookrunner
$ 143,893,750
Joint Bookrunner
$ 862,500,000
Lead Manager
$ 104,500,000
Sole Placement Agent
$ 55,300,000
Sole Bookrunner
$ 1,200,000,000
Advisor to Seller
$ 250,000,000
Joint Bookrunner
C$ 34,511,565
Joint Bookrunner
£ 34,261,864
Joint Bookrunner
$ 108,000,000
Joint Bookrunner
Advisor to Seller
$ 200,000,000
Joint Bookrunner
$ 230,000,000
Joint Bookrunner
€ 15,000,000
Joint Global Coordinator and Joint Bookrunner
$ 30,000,000
Sole Financial Advisor and Sole Placement Agent
$ 230,000,000
Joint Bookrunner
$ 75,000,000
Left Bookrunner
$ 40,000,000
Financial Advisor
$ 2,350,000,000
Joint Bookrunner
$ 100,000,000
Joint Bookrunner
$ 98,000,000
Joint Bookrunner
Advisor to Seller
$ 52,325,000
Joint Bookrunner
C$ 65,000,000
Co-Lead Manager
$ 172,500,000
Left Bookrunner
$ 80,500,000
Joint Bookrunner
$ 43,000,000
Lead Placement Agent
$ 100,800,000
Joint Bookrunner
$ 158,000,000
Capital Markets Advisor
Advisor to Seller
$ 230,000,000
Joint Bookrunner
$ 93,600,000
Joint Bookrunner
$ 150,750,000
Joint Bookrunner
C$ 7,004,400
Joint Bookrunner
$ 74,865,000
Joint Bookrunner
$ 345,000,000
Joint Bookrunner
$ 70,900,000
Advisor to Buyer
Advisor to Seller
$ 13,200,000
Joint Bookrunner
Advisor to Buyer
$ 1,000,000,000
Joint Bookrunner
$ 651,000,000
Capital Markets Advisor
Advisor to Buyer
$ 212,000,000
Capital Markets Advisor
$ 355,810,000
Joint Bookrunner
$ 84,333,337
Joint Bookrunner
$ 230,000,000
Joint Bookrunner
Advisor to Seller
£ 17,000,000
Sole Global Coordinator, Joint Bookrunner & Nomad
$ 174,560,000
Joint Bookrunner
$ 180,132,080
Joint Bookrunner
$ 62,675,000
Joint Bookrunner
$ 100,190,000
Joint Bookrunner
$ 350,000,000
Joint Bookrunner
$ 97,807,500
Joint Bookrunner
$ 181,500,000
Advisor to Seller
$ 160,000,000
Joint Bookrunner
$ 160,000,000
Joint Bookrunner
$ 80,000,000
Left Bookrunner
Advisor to Seller
$ 366,000,000
Co-Manager
$ 98,325,000
Joint Bookrunner
$ 100,912,500
Joint Bookrunner
$ 287,500,000
Joint Bookrunner
$ 646,875,000
Joint Bookrunner
$ 550,000,000
Joint Bookrunner
$ 103,500,000
Joint Bookrunner
$ 50,652,000
Left Bookrunner
$ 30,000,000
Joint Bookrunner
$ 48,000,000
Joint Bookrunner
$ 56,000,000
Joint Bookrunner
$ 55,000,000
Joint Placement Agent
$ 218,500,000
Joint Bookrunner
$ 115,000,000
Joint Bookrunner
$ 160,425,000
Joint Bookrunner
$ 138,250,000
Sole Bookrunner
$ 90,000,000
Advisor to Squadron
$ 222,250,000
Joint Bookrunner
$ 60,000,000
Joint Bookrunner
$ 2,200,000,000
Co-Manager
$ 150,000,000
Joint Bookrunner
$ 42,000,000
Sole Bookrunner
$ 264,500,000
Joint Bookrunner
$ 203,439,942
Joint Bookrunner
$ 117,000,000
Joint Bookrunner
Capital Markets Advisor
£ 40,000,000
Sole Placement Agent
$ 74,500,000
Left Bookrunner
$ 70,000,000
Joint Placement Agent
$ 129,375,000
Joint Bookrunner
$ 168,000,000
Joint Bookrunner
$ 103,500,000
Joint Bookrunner
$ 264,000,000
Joint Bookrunner
$ 555,450,000
Joint Bookrunner
$ 149,500,000
Joint Bookrunner
$ 200,000,000
Joint Bookrunner
$ 345,080,500
Joint Bookrunner
$ 312,225,000
Joint Bookrunner
$ 750,000,000
Joint Bookrunner
$ 277,725,000
Joint Bookrunner
$ 1,863,000,000
Joint Bookrunner
$ 81,176,464
Joint Bookrunner
$ 345,000,000
Lead Manager
$ 104,796,260
Left Bookrunner
$ 1,898,938,296
Joint Financial Advisor
$ 2,128,500,000
Lead Manager
$ 200,000,000
Joint Bookrunner
$ 277,761,104
Joint Bookrunner
$ 267,696,966
Joint Bookrunner
$ 963,470,000
Joint Bookrunner
$ 140,000,000
Advisor to Seller
$ 140,000,000
Advisor to Seller
$ 135,000,000
Advisor to Buyer
$ 445,000,000
Financial Advisor
$ 209,000,000
Joint Bookrunner
$ 80,000,000
Lead Placement Agent
$ 120,000,000
Joint Bookrunner
$ 39,054,798
Advisor to Buyer
$ 79,347,051
Joint Bookrunner
$ 125,000,000
Financial Advisor
Advisor to Seller